Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.016 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.025 0.6
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.6
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.016 0.6
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.025 0.6
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.015 0.6
Download CSV